-
EMUC21 shines spotlight on best poster winners
November 27, 2021Demonstrating the multidisciplinary nature of the congress, an oncologist, a radiotherapist, and a urologist each received a Best Poster...
00 -
Bladder-preserving strategies unveiled: Topical therapy and TURBT
November 26, 2021In order to preserve the quality of life for non-muscle-invasive bladder cancer (NMIBC) patients as much as possible, bladder-preserving...
-
Plenary Session 3: Promising biomarkers and novel approaches for patients with BCG failure
November 26, 2021Presenter Prof. Paolo Gontero (IT) launched Plenary Session 3 “Bladder cancer: Bladder-preserving strategies in NMIBC” at EMUC21 today with...
-
PSMA PET/CT: Prime tool in staging and treatment monitoring
November 26, 2021Plenary Session 1 “Prostate cancer staging in 2021: Where are we, where are we going?” provided delegates with expert...
-
Strengths and limitations of PSMA PET: When to use it (and when not to)
November 26, 2021The prostate-specific membrane antigen positron emission tomography (PSMA PET) scan is the (relatively) new kid on the block in...
-
Expectations for new WHO classification and what’s next in PCa grading
November 25, 2021The EMUC Symposium on Genitourinary Pathology and Molecular Diagnostics (ESUP) delivered updates and expert insights on topics such as...
-
Definitive: EMUC21 is coming to Athens!
September 24, 2021New crucial updates in GU cancer prevention, diagnosis and management Relive and enjoy the congress experience, meet and connect...
-
Radioligand therapy: multidisciplinary collaboration for health system readiness
September 13, 2021By the European Society for Medical Oncology (ESMO) team Join the EMUC21 session ‘Radioligand therapy: multidisciplinary collaboration for health...
-
New developments in imaging have great potential to change treatment in the coming years
November 14, 2020There are several promising imaging techniques on the horizon, with the potential of changing the way oncology experts treat...
-
EMUC20: Highlights in GU cancers
November 13, 2020Active surveillance should be considered the first treatment for prostate cancer in order to ensure the best quality of...
News
EMUC24 > News
